[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE203545T1 - Substrate und inhibitoren von proteolytischen enzymen - Google Patents

Substrate und inhibitoren von proteolytischen enzymen

Info

Publication number
ATE203545T1
ATE203545T1 AT97918252T AT97918252T ATE203545T1 AT E203545 T1 ATE203545 T1 AT E203545T1 AT 97918252 T AT97918252 T AT 97918252T AT 97918252 T AT97918252 T AT 97918252T AT E203545 T1 ATE203545 T1 AT E203545T1
Authority
AT
Austria
Prior art keywords
inhibitors
proteolytic enzymes
substrates
proteases
indentification
Prior art date
Application number
AT97918252T
Other languages
English (en)
Inventor
Martin Quibell
Tony Johnson
Terance Hart
Original Assignee
Medivir Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9608457.9A external-priority patent/GB9608457D0/en
Priority claimed from GBGB9616115.3A external-priority patent/GB9616115D0/en
Priority claimed from GBGB9624584.0A external-priority patent/GB9624584D0/en
Application filed by Medivir Uk Ltd filed Critical Medivir Uk Ltd
Application granted granted Critical
Publication of ATE203545T1 publication Critical patent/ATE203545T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00306—Reactor vessels in a multiple arrangement
    • B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315—Microtiter plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00504—Pins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97918252T 1996-04-24 1997-04-24 Substrate und inhibitoren von proteolytischen enzymen ATE203545T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9608457.9A GB9608457D0 (en) 1996-04-24 1996-04-24 Inhibitors of proteolytic enzymes
GBGB9616115.3A GB9616115D0 (en) 1996-07-31 1996-07-31 Substrate and inhibitors of proteolytic enzymes
GBGB9624584.0A GB9624584D0 (en) 1996-11-27 1996-11-27 Substances and inhibitors of proteolytic enzymes
PCT/GB1997/001157 WO1997040065A2 (en) 1996-04-24 1997-04-24 Substrates and inhibitors of proteolytic enzymes

Publications (1)

Publication Number Publication Date
ATE203545T1 true ATE203545T1 (de) 2001-08-15

Family

ID=27268257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918252T ATE203545T1 (de) 1996-04-24 1997-04-24 Substrate und inhibitoren von proteolytischen enzymen

Country Status (10)

Country Link
US (2) US6528275B1 (de)
EP (2) EP0906333B1 (de)
JP (2) JP4215822B2 (de)
AT (1) ATE203545T1 (de)
AU (2) AU706855B2 (de)
CA (2) CA2252408A1 (de)
DE (1) DE69705838T2 (de)
DK (1) DK0906333T3 (de)
ES (1) ES2162277T3 (de)
WO (2) WO1997042216A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149869A (en) * 1996-10-23 2000-11-21 Glaxo Wellcome Inc. Chemical synthesizers
US6042789A (en) * 1996-10-23 2000-03-28 Glaxo Group Limited System for parallel synthesis of organic compounds
EP0937253A1 (de) * 1996-10-31 1999-08-25 Novalon Pharmaceutical Corporation Identifizierung von medikamenten zur verwendung von kombinatorischen bibliotheken
US6617114B1 (en) 1996-10-31 2003-09-09 Karo Bio Ab Identification of drug complementary combinatorial libraries
US6054325A (en) * 1996-12-02 2000-04-25 Glaxo Wellcom Inc. Method and apparatus for transferring and combining distinct chemical compositions with reagents
US6083761A (en) * 1996-12-02 2000-07-04 Glaxo Wellcome Inc. Method and apparatus for transferring and combining reagents
GB9722818D0 (en) * 1997-10-30 1997-12-24 Peptide Therapeutics Ltd A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
WO1999026902A1 (en) * 1997-11-26 1999-06-03 Peptide Therapeutics Limited A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring
US6083682A (en) * 1997-12-19 2000-07-04 Glaxo Group Limited System and method for solid-phase parallel synthesis of a combinatorial collection of compounds
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6569636B2 (en) * 1998-05-29 2003-05-27 Hawaii Biotechnology Group, Inc. Assay for modulators of metallo-enzyme activity
DE19925402C2 (de) * 1999-06-02 2001-12-20 Molecular Machines & Ind Gmbh Screening von Target-Ligand-Wechselwirkungen
AU2001262906A1 (en) * 2000-02-11 2001-08-20 Cellomics, Inc. Peptide biosensors for anthrax protease
JP2002250730A (ja) * 2001-02-27 2002-09-06 Shinwa Kako Kk 分子センサー及びその製造方法
MY140707A (en) 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
JP2005535710A (ja) * 2002-08-09 2005-11-24 トランス　テック　ファーマ，インコーポレイテッド アリールおよびヘテロアリール化合物ならびに凝固を調節する方法
US7459472B2 (en) 2003-08-08 2008-12-02 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US8015064B2 (en) * 2005-04-20 2011-09-06 At&T Intellectual Property I, Lp System and method of providing advertisements to cellular devices
ATE442438T1 (de) * 2005-07-26 2009-09-15 Council Scient Ind Res Verfahren zur identifizierung von die stresstoleranz in hefe erhíhenden genen sowie verwendung dieser gene zur verbesserung von hefestämmen
US9267952B2 (en) 2008-11-05 2016-02-23 Morphosys Ag Deconvolution method
EP2189536A1 (de) * 2008-11-20 2010-05-26 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Schnelle Anthrax-Diagnose auf FRET-Basis
WO2010059051A2 (en) * 2008-11-20 2010-05-27 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Rapid fret based pathogen diagnosis
KR102668696B1 (ko) 2012-01-12 2024-05-29 예일 유니버시티 E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
WO2017079267A1 (en) 2015-11-02 2017-05-11 Yale University Proteolysis targeting chimera compounds and methods of preparing and using same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (de) 1989-11-03 1991-05-22 Abbott Laboratories Fluorogene Substrate zum Nachweis von proteolytischer Enzymaktivität
US5164300A (en) 1989-12-28 1992-11-17 Washington University Method for determining activity of retroviral protease
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease
DK93990D0 (da) 1990-04-17 1990-04-17 Carlsberg As Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet
HU9201687D0 (en) 1992-05-21 1992-08-28 Arpad Furka Preparation of sets from peptid mixtures with polycomponents and their use for the identification of biologically active peptides
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
JPH09506611A (ja) 1993-12-15 1997-06-30 コンビケム，インコーポレイテッド 組合わせライブラリーおよびその使用法
US5506115A (en) 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
US5738996A (en) * 1994-06-15 1998-04-14 Pence, Inc. Combinational library composition and method
JP2000503533A (ja) * 1996-01-04 2000-03-28 ネーデルランドセ・オルガニザテイエ・フール・テゲパスト―ナトウールベテンシヤツペリーク・オンデルツエク・テイエヌオー 蛍光消光基質を用いたタンパク質分解酵素のアッセイ方法
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials

Also Published As

Publication number Publication date
ES2162277T3 (es) 2001-12-16
AU706855B2 (en) 1999-06-24
EP0906333B1 (de) 2001-07-25
EP0906334A1 (de) 1999-04-07
DE69705838T2 (de) 2002-04-11
AU728263B2 (en) 2001-01-04
CA2252408A1 (en) 1997-11-13
AU2645097A (en) 1997-11-26
DE69705838D1 (de) 2001-08-30
JP2000512979A (ja) 2000-10-03
JP4215822B2 (ja) 2009-01-28
US6528275B1 (en) 2003-03-04
CA2252508A1 (en) 1997-10-30
WO1997042216A1 (en) 1997-11-13
JP2001501170A (ja) 2001-01-30
WO1997040065A2 (en) 1997-10-30
WO1997040065A3 (en) 1997-12-04
AU2644997A (en) 1997-11-12
DK0906333T3 (da) 2001-11-12
US20030092067A1 (en) 2003-05-15
EP0906333A2 (de) 1999-04-07

Similar Documents

Publication Publication Date Title
ATE203545T1 (de) Substrate und inhibitoren von proteolytischen enzymen
DE69731226D1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
DE69938766D1 (de) Verfahren zur Rückgewinnung von Substratscheiben
ATA2998A (de) Verfahren und vorrichtung zum ausgerichteten zusammenführen von scheibenförmigen halbleitersubstraten
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
DE69718142D1 (de) Verfahren zum ätzen von halbleiterscheiben
DE69818304D1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
DE69636183D1 (de) Vorrichtung zur Prüfung von Halbleitersubstraten
DE69835532D1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
BR0008625A (pt) Processo para tratamento de asma induzida por exercìcio
DK0871454T3 (da) Phosphorholdige inhibitorer af cystein- og serinprotease
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
DE59905412D1 (de) Verfahren zum Betreiben von Turboverdichtern
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
DE69012319D1 (de) Verfahren zur entfernung von beschichtungen empfindlicher substrate und werfmedia dazu.
DE69934948D1 (de) Verfahren zur cooxidation von organischen verbindungen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
MX9805948A (es) Substratos e inhibidores para proteasa de cisteina ich-1.
DE69835376D1 (de) Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität
DE59804666D1 (de) Drehvorrichtung zur plasma-immersions-gestützten behandlung von substraten
DE60331414D1 (de) Aggrecanase-1- und -2-peptidsubstrate und verfahren
ATE343002T1 (de) Verfahren zur isolation des 20s proteasoms, und verfahren zur identifikation von inhibitoren des 20s und 26s proteasoms
ATE323173T1 (de) Nährboden zum nachweis und/oder zur unterscheidung von enterokokken
DE69932342D1 (de) Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties